Pulse Biosciences, Inc. (PLSE) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 10.98M USD | Liabilities, Current |
| Cash and equivalents | 101.62M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 122.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 236.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $10.98M | $101.62M | (m) | $122.00K | $236.00K | (m) |
| 2026-03-31 | (m) | $9.80M | $68.32M | (m) | $157.00K | $206.00K | (m) |
| 2025-12-31 | (m) | $7.92M | $80.73M | (m) | $274.00K | $136.00K | (m) |
| 2025-09-30 | (m) | $9.70M | $95.21M | (m) | $15.00K | $57.00K | (m) |
| 2025-06-30 | (m) | $8.98M | $106.35M | (m) | (m) | $51.00K | (m) |
| 2025-03-31 | (m) | $7.76M | $119.28M | (m) | (m) | $30.00K | (m) |
| 2024-12-31 | (m) | $10.05M | $118.04M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $6.74M | $79.03M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $5.96M | $26.20M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $5.08M | $34.88M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $6.71M | $44.37M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $5.43M | $50.39M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $5.61M | $58.75M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $6.99M | $54.10M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $5.98M | $61.14M | (m) | $0.00 | $0.00 | (m) |
| 2022-09-30 | (m) | $7.00M | $69.16M | (m) | $5.00K | $750.00K | (m) |
| 2022-06-30 | (m) | $7.56M | $14.80M | (m) | $8.00K | $7.87M | (m) |
| 2022-03-31 | (m) | $8.90M | $12.68M | (m) | $21.00K | $7.49M | (m) |
| 2021-12-31 | (m) | $8.52M | $28.61M | (m) | $61.00K | $5.82M | (m) |
| 2021-09-30 | (m) | $9.52M | $41.99M | (m) | $72.00K | $4.28M | (m) |
| 2021-06-30 | (m) | $9.84M | $47.43M | (m) | (m) | $2.69M | (m) |
| 2021-03-31 | (m) | $8.53M | $59.88M | (m) | (m) | $1.14M | (m) |
| 2020-12-31 | (m) | $7.58M | $12.46M | $8.01M | (m) | (m) | (m) |
| 2020-09-30 | (m) | $6.00M | $7.07M | $22.52M | (m) | (m) | (m) |
| 2020-06-30 | (m) | $4.89M | $37.77M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $3.38M | $7.86M | $8.02M | (m) | (m) | (m) |
| 2019-12-31 | (m) | $4.46M | $6.90M | $18.50M | (m) | (m) | (m) |
| 2019-09-30 | (m) | $4.05M | $9.57M | $24.93M | (m) | (m) | (m) |
| 2019-06-30 | (m) | $3.45M | $10.78M | $31.86M | (m) | (m) | (m) |
| 2019-03-31 | (m) | $3.12M | $8.54M | $44.27M | (m) | (m) | (m) |
| 2018-12-31 | (m) | $3.11M | $51.10M | $8.48M | (m) | (m) | (m) |
| 2018-09-30 | (m) | $3.35M | $6.33M | $14.69M | (m) | (m) | (m) |
| 2018-06-30 | (m) | $3.07M | $6.79M | $20.70M | (m) | (m) | (m) |
| 2018-03-31 | (m) | $2.19M | $10.67M | $22.71M | (m) | (m) | (m) |
| 2017-12-31 | (m) | $2.21M | $3.39M | $34.68M | (m) | (m) | (m) |
| 2017-09-30 | (m) | $2.47M | $32.42M | $9.62M | (m) | (m) | (m) |
| 2017-06-30 | (m) | $1.97M | $1.99M | $13.41M | (m) | (m) | (m) |
| 2017-03-31 | (m) | $1.24M | $2.75M | $16.11M | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.02M | $2.09M | $14.31M | (m) | (m) | (m) |
| 2016-09-30 | (m) | $967.00K | $4.63M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $590.00K | $20.21M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $650.00K | $2.10M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $660.00K | $3.61M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $4.95M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | $5.94M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | $6.55M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $7.01M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |